FDA Inspection 1283498 — SGS France Life Sciences

SGS France Life Sciences — FEI 3036828522

The FDA completed an inspection of SGS France Life Sciences on August 29, 2025 in Saint-Benoit. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 29, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Saint-Benoit (France)

Additional Details

Bioanalytical BA/BE